Blue Jay Capital Management as of Dec. 31, 2016
Portfolio Holdings for Blue Jay Capital Management
Blue Jay Capital Management holds 15 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Clovis Oncology | 8.0 | $13M | 299k | 44.42 | |
| Qiagen | 7.4 | $12M | 439k | 28.02 | |
| Tesaro | 7.3 | $12M | 90k | 134.48 | |
| Ironwood Pharmaceuticals (IRWD) | 7.1 | $12M | 772k | 15.29 | |
| C.R. Bard | 7.1 | $12M | 52k | 224.66 | |
| Alexion Pharmaceuticals | 6.7 | $11M | 90k | 122.35 | |
| Incyte Corporation (INCY) | 6.6 | $11M | 109k | 100.27 | |
| Hologic (HOLX) | 6.6 | $11M | 274k | 40.12 | |
| Laboratory Corp. of America Holdings (LH) | 6.6 | $11M | 85k | 128.38 | |
| Boston Scientific Corporation (BSX) | 6.5 | $11M | 498k | 21.63 | |
| Shire | 6.4 | $11M | 63k | 170.38 | |
| Dermira | 6.4 | $11M | 350k | 30.33 | |
| Bristol Myers Squibb (BMY) | 6.0 | $9.9M | 170k | 58.44 | |
| Edwards Lifesciences (EW) | 5.8 | $9.7M | 103k | 93.70 | |
| ResMed (RMD) | 5.4 | $9.0M | 145k | 62.05 |
